Secur-Fit Advanced Outcomes Study

Inclusion Criteria:

- Patient has signed an Institutional Review Board (IRB)/Ethics Committee (EC) approved,
study specific Informed Patient Consent Form.

- Patient is a male or non-pregnant female, skeletally mature and age 21-75 years at
time of study device implantation.

- Patient has a diagnosis of Non-Inflammatory Degenerative Joint Disease.

- Patient is a candidate for primary total hip arthroplasty.

- Patient is willing and able to comply with postoperative scheduled clinical and
radiographic evaluations and rehabilitation.

Exclusion Criteria:

- Patient has previously undergone open surgical intervention on the operative hip.

- Patient has a prior femoral fracture, with or without deformity, on the operative
side.

- Patient has an existing total hip replacement on the contralateral side.

- Patient requires simultaneous bilateral total hip replacement.

- Patient has a Body Mass Index (BMI) > 45.

- Patient has an active or suspected latent infection in or about the affected hip joint
at time of study device implantation.

- Patient has a neuromuscular or neurosensory deficiency that would create an
unacceptable risk of instability, prosthesis fixation failure or complications in
postoperative care, or which limits the ability to evaluate the safety and efficacy of
the device.

- Patient has bone stock that is inadequate for support or fixation of the prosthesis,
or is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic
disorder (e.g. Paget's disease) leading to progressive bone deterioration.

- Patient is immunologically suppressed or receiving steroids in excess of normal
physiological requirements (e.g. > 30 days).

- Patient has a known sensitivity to device materials.

- Patient is a prisoner.